Search clinical trials for: G-CSF

Total 3446 results

Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fed Conditions

Healthy

India
University of Liverpool
Genzyme, a Sanofi Company

Unknown

Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC) (PHANTASTIC)

Lymphoma | Lymphoproliferative Disorders | Multiple Myeloma | Plasma Cell Dyscrasia

United Kingdom
Centre Georges Francois Leclerc

Completed

Evaluation and Modeling of the G-CSF Effect on the Evolution of Neutrophils During Chemotherapy Based on Eribulin (EMEG-E-01)

Breast Cancer

France
Eli Lilly and Company

Completed

A Study for Participants With Small-Cell Lung Cancer

Small Cell Lung Cancer

United States, Korea, Republic of, Romania
Center for Human Reproduction
Foundation for Reproductive Medicine

Terminated

Effect of Colony Stimulating Factor on Poor Endometrial Development During IVF

Infertility, Female

United States
Proacta, Incorporated

Terminated

Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer

United States, Canada, New Zealand
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult... and other conditions

United States
BeyondSpring Pharmaceuticals Inc.
Covance; ICON plc

Completed

Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 (Protective-1)

Chemotherapy-induced Neutropenia

China, Russian Federation, United States, Ukraine
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Multiple Myeloma | Cutaneous Lymphoma

Australia
Medline Industries

Completed

Antimicrobial Efficacy of 2% CHG (Chlorhexidine Gluconate)

Healthy
South Valley University

Completed

Filgrastim for Premature Ovarian Insufficiency (FIL-POI)

Premature Ovarian Failure
Genzyme, a Sanofi Company

Completed

Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients

Lymphoma, Non-Hodgkin | Multiple Myeloma

United States
Genzyme, a Sanofi Company
AnorMED

Completed

Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

Lymphoma, Non-Hodgkin | Multiple Myeloma

Germany
Dipnarine Maharaj

Enrolling by invitation

Safety, Efficacy of FFP From Healthy Donors to AmeliorateFrailty and Enhance Immune Function in Older Individuals

Frailty

United States
Instituto de Investigacion Sanitaria La Fe

Unknown

Autologous Bone Marrow Stem Cell Ovarian Transplantation to Restore Ovarian Function in Premature Ovarian Failure (ASCOT-2)

Premature Ovarian Failure (POF)

Spain
Genzyme, a Sanofi Company

Terminated

AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone

Multiple Myeloma | Lymphoma, Non-Hodgkin's

United States
Duke University
Genzyme, a Sanofi Company

Completed

Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant

Multiple Myeloma | Non-Hodgkins Lymphoma | Hodgkins Disease

United States
Genzyme, a Sanofi Company
AnorMED

Completed

Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

Lymphoma, Non-Hodgkin | Multiple Myeloma

United States
Rigshospitalet, Denmark

Completed

Stem Cells in Myocardial Infarction

Acute Myocardial Infarction

Denmark
Chang Gung Memorial Hospital

Recruiting

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

Neutropenia | Pediatric Cancer | G-CSF | Lenograstim | Filgrastim

Taiwan
Genzyme, a Sanofi Company

Completed

AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF

Lymphoma, Non-Hodgkin | Multiple Myeloma

Canada
Gazi University

Completed

Gingival Recession Treatment With Concentrated Growth Factor(CGF)

Gingival Recession
Orasis Pharmaceuticals Ltd.

Completed

A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia

Presbyopia

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Esophageal Cancer

United States
Shandong University

Unknown

Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients

Acute Myeloid Leukemia

China
Therapeutic Advances in Childhood Leukemia Consortium

Completed

Epigenetic Reprogramming in Relapse/Refractory AML

Acute Myelogenous Leukemia

United States, Canada, Australia
Bulent Ecevit University

Completed

Growth Factors in the Treatment of the Multiple Gingival Recessions

Gingival Recession | Growth Factors, Combined Defect of

Turkey
EVIVE Biotechnology
Zhejiang Cancer Hospital; Fudan University; RenJi Hospital; Henan Cancer Hospital; Tongji Hospital and other collaborators

Completed

A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.

Neutropenia

China
Seoul National University Hospital

Terminated

Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion

Myocardial Infarction

Korea, Republic of
The First Hospital of Jilin University

Recruiting

Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma

Lymphoma | Chemotherapy-induced Neutropenia

China
University of British Columbia

Completed

Cerebrospinal Fluid (CSF) Drainage and Cytokine Profiling in the Treatment of Acute Spinal Cord Injury (SCI)

Spinal Cord Injuries

Canada
Peking University

Unknown

PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Lymphoma

China
Deutsches Herzzentrum Muenchen
Else Kröner Fresenius Foundation; Wilhelm Sander Foundation; Schulz Foundation

Completed

Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)

Myocardial Infarction

Germany
Mayo Clinic

Completed

Study of Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis

Atherosclerosis, Coronary

United States
Genzyme, a Sanofi Company

Completed

AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts

Autologous Stem Cell Transplantation

United States
Proacta, Incorporated

Completed

PR104 and G-CSF in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States, New Zealand
Air Force Military Medical University, China

Unknown

To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer

Cervical Cancer

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia

Leukemia

United States
Genzyme, a Sanofi Company

Completed

Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).

Multiple Myeloma | Autologous Transplantation
Xiamen Amoytop Biotech Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Completed

Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

Non-Myeloid Malignancy

China
Washington University School of Medicine

Completed

Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma

Lymphoma, Non-Hodgkin | Hodgkin Disease

United States
St. Jude Children's Research Hospital
GlaxoSmithKline; National Institutes of Health (NIH)

Completed

A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor

Wilms Tumor

United States, Canada
Chongqing University Cancer Hospital
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Recruiting

Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells

Lymphoma

China
Sun Yat-sen University
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

PEG-rhG-CSF Compared With rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Lymphoma
Mylan Inc.
Mylan GmbH

Completed

Efficacy and Safety Study With MYL-1401H and Neulasta

Breast Neoplasms | Chemotherapy-Induced Febrile Neutropenia

Bulgaria, Georgia, Germany, Hungary, Poland, Ukraine
Stephen Couban
Genzyme, a Sanofi Company

Completed

Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor

Malignant Lymphoma, Stem Cell Type

Canada
Barts & The London NHS Trust

Completed

Bone Marrow Derived Adult Stem Cells for Chronic Heart Failure (REGEN-IHD)

Chronic Ischaemic Heart Failure

United Kingdom
National Cancer Institute (NCI)

Completed

Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors

Recurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Childhood Choroid Plexus Tumor | Childhood Craniopharyngioma | Childhood Ependymoblastoma | Childhood Grade I Meningioma | Childhood Grade II Meningioma | Childhood Grade III Meningioma | Childhood High-grade Cerebellar Astrocytoma | Childhood High-grade Cerebral Astrocytoma and other conditions

United States
Gynecologic Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Completed

Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Stage III Uterine Corpus Cancer | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous Carcinoma | Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Lymphoma

United States

Search clinical trials for: G-CSF

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations